COR388

· Cortexyme

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COR388, covering 2023-02-23 to 2023-02-23. Get the full timeline:

Most recent: Clinical Trial Update: GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease [Phase 2, Phase 3]